| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $783.5M | — | +6.4% |
| R&D Expense | $13.5M | — | -3.8% |
| SG&A Expense | $71.8M | — | +4.7% |
| Operating Income | $95.4M | — | +84.4% |
| Pre-tax Income | $21.1M | — | -70.7% |
| Income Tax | $16.9M | — | +12.5% |
| Net Income | -$15.2M | — | -146.0% |
| EPS (Basic) | -$1.54 | — | -165.5% |
| EPS (Diluted) | -$1.54 | — | -170.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $500.8M | -46.8% | +26.3% |
| Short-term Investments | $46K | +48.4% | -99.4% |
| Accounts Receivable | $417.7M | +6.6% | -24.0% |
| Inventory | $90.2M | -4.9% | -23.0% |
| Current Assets | $1.15B | -25.7% | -3.9% |
| Total Assets | $4.39B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $113.3M | — | +29.2% |
| Capital Expenditures | $165.0M | — | +0.0% |
| Investing Cash Flow | -$169.5M | — | -126.2% |
| Financing Cash Flow | -$383.2M | — | — |
| Free Cash Flow | -$51.6M | — | +33.2% |
| -13.2% |
| Current Liabilities | $585.2M | -41.1% | -12.3% |
| Long-term Debt | $2.12B | +0.1% | -21.1% |
| Total Liabilities | $2.94B | -12.2% | -18.3% |
| Stockholders' Equity | $568.9M | -3.7% | +66.0% |